Jan C. Van Der Meijden
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The role of renin, fludrocortisone, and hypertension in early childhood in patients with congenital adrenal hyperplasia.
Journal: European journal of endocrinology
Published: March 21, 2026
The Metabolic Treatabolome and Inborn Errors of Metabolism Knowledgebase therapy tool: Do not miss the opportunity to treat!
Journal: Journal of inherited metabolic disease
Published: July 10, 2024
The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease.
Journal: PloS one
Published: September 12, 2018
Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure.
Journal: Journal of inherited metabolic disease
Published: March 21, 2018
Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients.
Journal: Orphanet journal of rare diseases
Published: January 29, 2018
Mucolipidosis type III, a series of adult patients.
Journal: Journal of inherited metabolic disease
Published: January 19, 2018
Long-term follow-up of 17 patients with childhood Pompe disease treated with enzyme replacement therapy.
Journal: Journal of inherited metabolic disease
Published: October 05, 2017
Association of Muscle Strength and Walking Performance in Adult Patients With Pompe Disease.
Journal: Physical therapy
Published: May 08, 2017
Long-term benefit of enzyme replacement therapy in Pompe disease: A 5-year prospective study.
Journal: Neurology
Published: April 29, 2017
A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI.
Journal: Molecular genetics and metabolism
Published: March 16, 2017
Childhood Pompe disease: clinical spectrum and genotype in 31 patients.
Journal: Orphanet journal of rare diseases
Published: March 03, 2016
Last Updated: 09/26/2026